The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing

Autor: Cliff L Wang, Jonathan V Feldstein, Hanlee P. Ji, Alison J. Kriegel, Shawn Levy, Christopher E. Mason, Feng Zhang, Jason Kelly, Junbiao Dai, Doug Schenkel, Ebrahim Afshinnekoo, Yizhi Cai, Anna C Hooker, Jeff Huber, Marc L. Salit, Subhalaxmi Nambi, Matthew MacKay, Nick Haft, George M. Church, Anne L. Wyllie

Publikováno v: Nat Biotechnol
Nature Biotechnology
MacKay, M J, Hooker, A C, Afshinnekoo, E, Salit, M, Kelly, J, Feldstein, J V, Haft, N, Schenkel, D, Nambi, S, Cai, Y, Zhang, F, Church, G, Dai, J, Wang, C L, Levy, S, Huber, J, Ji, H P, Kriegel, A, Wyllie, A L & Mason, C E 2020, ' The COVID-19 XPRIZE and the need for scalable, fast, and widespread testing ', Nature biotechnology, vol. 38, no. 9, pp. 1021-1024 . https://doi.org/10.1038/s41587-020-0655-4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222e0cbddf807e7f3261bf645d3bab98
https://pubmed.ncbi.nlm.nih.gov/32820257